Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls

References

• Levenson VV. Biomarkers for early detection of breast cancer: what, when, and where?. Biochim Biophys Acta 2007; 1770:847 - 56; http://dx.doi.org/10.1016/j.bbagen.2007.01.017; PMID: 17368950
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk KP, van Diest PJ, van der Wall E. Improving early breast cancer detection: focus on methylation. Ann Oncol 2011; 22:24 - 9; http://dx.doi.org/10.1093/annonc/mdq305; PMID: 20591821
   PubMed Web of Science ®Google Scholar
• Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002; 21:5462 - 82; http://dx.doi.org/10.1038/sj.onc.1205606; PMID: 12154408
   PubMed Web of Science ®Google Scholar
• Campan M, Weisenberger DJ, Laird PW. DNA methylation profiles of female steroid hormone-driven human malignancies. Curr Top Microbiol Immunol 2006; 310:141 - 78; http://dx.doi.org/10.1007/3-540-31181-5_8; PMID: 16909910
   PubMed Web of Science ®Google Scholar
• Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004; 64:4442 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-03-3341; PMID: 15231653
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61:3225 - 9; PMID: 11309270
   PubMed Web of Science ®Google Scholar
• Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, et al. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003; 107:970 - 5; http://dx.doi.org/10.1002/ijc.11508; PMID: 14601057
   PubMed Web of Science ®Google Scholar
• Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007; 635:105 - 17; http://dx.doi.org/10.1016/j.mrrev.2006.11.002; PMID: 17257890
   PubMed Web of Science ®Google Scholar
• Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 2004; 10:6189 - 93; http://dx.doi.org/10.1158/1078-0432.CCR-04-0597; PMID: 15448006
   PubMed Web of Science ®Google Scholar
• Hibi K, Nakao A. [Molecular detection of tumor DNA in the serum of colorectal cancer patients]. Nihon Rinsho 2003; 61:Suppl 7 197 - 200; PMID: 14574881
   PubMedGoogle Scholar
• Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61:1659 - 65; PMID: 11245480
   PubMed Web of Science ®Google Scholar
• Kohler C, Barekati Z, Radpour R, Zhong XY. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res 2011; 31:2623 - 8; PMID: 21778314
   PubMed Web of Science ®Google Scholar
• van der Vaart M, Pretorius PJ. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?. Clin Biochem 2010; 43:26 - 36; http://dx.doi.org/10.1016/j.clinbiochem.2009.08.027; PMID: 19747472
   PubMed Web of Science ®Google Scholar
• Brooks J, Cairns P, Zeleniuch-Jacquotte A. Promoter methylation and the detection of breast cancer. Cancer Causes Control 2009; 20:1539 - 50; http://dx.doi.org/10.1007/s10552-009-9415-y; PMID: 19768562
   PubMed Web of Science ®Google Scholar
• Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 2006; 24:4262 - 9; http://dx.doi.org/10.1200/JCO.2005.01.3516; PMID: 16908936
   PubMed Web of Science ®Google Scholar
• Brooks JD, Cairns P, Shore RE, Klein CB, Wirgin I, Afanasyeva Y, et al. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol 2010; 34:717 - 23; http://dx.doi.org/10.1016/j.canep.2010.05.006; PMID: 20627767
   PubMed Web of Science ®Google Scholar
• Swift-Scanlan T, Vang R, Blackford A, Fackler MJ, Sukumar S. Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther 2011; 11:853 - 65; http://dx.doi.org/10.4161/cbt.11.10.15177; PMID: 21383541
   PubMed Web of Science ®Google Scholar
• Breiman L. Random forests. Mach Learn 2001; 45:5; http://dx.doi.org/10.1023/A:1010933404324
   Web of Science ®Google Scholar
• Van De Voorde L, Speeckaert R, Van Gestel D, Bracke M, De Neve W, Delanghe J, et al. DNA methylation-based biomarkers in serum of patients with breast cancer. Mutat Res 2012; In press; PMID: 22698615
   PubMed Web of Science ®Google Scholar
• Brait M, Ford JG, Papaiahgari S, Garza MA, Lee JI, Loyo M, et al. Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev 2009; 18:2984 - 91; http://dx.doi.org/10.1158/1055-9965.EPI-08-1245; PMID: 19861513
   PubMed Web of Science ®Google Scholar
• Zanetti-Dällenbach R, Wight E, Fan AX, Lapaire O, Hahn S, Holzgreve W, et al. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res 2008; 28:2A 921 - 5; PMID: 18507037
   PubMed Web of Science ®Google Scholar
• Euhus DM, Bu D, Milchgrub S, Xie XJ, Bian A, Leitch AM, et al. DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17:1051 - 9; http://dx.doi.org/10.1158/1055-9965.EPI-07-2582; PMID: 18483325
   PubMed Web of Science ®Google Scholar
• Fitzgibbons PL, Henson DE, Hutter RV, Cancer Committee of the College of American Pathologists. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Arch Pathol Lab Med 1998; 122:1053 - 5; PMID: 9870852
   PubMed Web of Science ®Google Scholar
• Masnyk IJ, Sears M, Corle D, Go VL, Dunsmore M. Serum bank for biological markers for breast cancer. J Natl Cancer Inst 1983; 71:875 - 6; PMID: 6578377
   PubMed Web of Science ®Google Scholar
• Storey JD. The positive false discovery rate. J R Stat Soc Series B Stat Methodol 2002; 64:479 - 98; http://dx.doi.org/10.1111/1467-9868.00346
   Web of Science ®Google Scholar